Avoro Capital Advisors β 2017 Investments
4 investments dated 2017 Β· listed companies and verified rows first Β· show all
Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders.
BiotechHealthtechLongevitySan Diego, US
Brian Lian(President, CEO & Director (Founder))Michael Morneau(Chief Financial Officer)Dr. Lian(President & Chief Executive Officer, Director)Stephen W. Webster(Director)Matthew W. Foehr(Director)
BoardJ. Matthew Singleton(Director)
Fennec Pharmaceuticals is a biotechnology company focused on treatments for cancer patients who experience hearing loss caused by chemotherapy.
BiotechHealthtechResearch Triangle Park, US
Krysia Lynes(Executive Officer)Rostislav Raykov(Executive Officer, Director)
BoardAdrian Haigh(Director)Steven Skolsky(Director)Chris Rallis(Director)Khalid Islam(Director)
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions.
BiotechHealthtechMedical DevicesPittsburgh, US
Suma M. Krishnan(Director)Krish S. Krishnan(Chairman & CEO)Suma Krishnan(President, Research & Development)inKrish Krishnan(Chairman & CEO)inDoug Norby(Director)Dino Rossi(Director)
Co-investorsFrazier Life SciencesAlta Partners
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.